Schauffler H H
Department of Social and Administrative Health Sciences, School of Public Health, University of California, Berkeley 94720.
Am J Prev Med. 1993 Mar-Apr;9(2):71-7.
I review the history and politics of Medicare disease prevention policy and identify factors associated with the success or failure of legislative initiatives to add preventive services benefits to Medicare. Between 1965 and 1990, 453 bills for Medicare preventive services were introduced in the U.S. Congress, but not until 1980, after 350 bills had failed, was the first preventive service added to the Medicare program. Medicare currently pays for only four of the 44 preventive services recommended for the elderly by the U.S. Preventive Services Task Force (pneumococcal and hepatitis B vaccinations, Pap smears, and mammography). In addition, Congress has funded demonstration programs for the influenza vaccine and comprehensive preventive services. The preventive services added to Medicare reflect the bias of the biomedical model toward screening and immunizations. Counseling services have received the least legislative attention. Factors associated with successful enactment include single-benefit bills, incorporation into budget-deficit reduction legislation, documented evidence of cost-effectiveness, public hearings, sponsorship by chairs of key congressional committees, and persistent congressional leadership. Factors associated with failure include lack of support from Medicare beneficiaries, lack of professional support, impact on total Medicare expenditures, disagreement over or failure to address payment and financing mechanisms, and competing congressional priorities.
我回顾了医疗保险疾病预防政策的历史和政治情况,并确定了与将预防性服务福利添加到医疗保险的立法举措成败相关的因素。1965年至1990年间,美国国会提出了453项医疗保险预防性服务法案,但直到1980年,在350项法案失败后,第一项预防性服务才被添加到医疗保险计划中。医疗保险目前只为美国预防服务工作组为老年人推荐的44项预防性服务中的四项付费(肺炎球菌和乙肝疫苗接种、巴氏涂片检查和乳房X光检查)。此外,国会还为流感疫苗和全面预防性服务的示范项目提供了资金。添加到医疗保险中的预防性服务反映了生物医学模式对筛查和免疫接种的偏向。咨询服务受到的立法关注最少。与成功颁布相关的因素包括单一福利法案、纳入减少预算赤字的立法、成本效益的书面证据、公开听证会、关键国会委员会主席的支持以及持续的国会领导。与失败相关的因素包括医疗保险受益人的缺乏支持、专业支持的缺乏、对医疗保险总支出的影响、对支付和融资机制的分歧或未能解决以及相互竞争的国会优先事项。